Literature DB >> 9346909

Nine L-type amino acid residues confer full 1,4-dihydropyridine sensitivity to the neuronal calcium channel alpha1A subunit. Role of L-type Met1188.

M J Sinnegger1, Z Wang, M Grabner, S Hering, J Striessnig, H Glossmann, J Mitterdorfer.   

Abstract

Pharmacological modulation by 1,4-dihydropyridines is a central feature of L-type calcium channels. Recently, eight L-type amino acid residues in transmembrane segments IIIS5, IIIS6, and IVS6 of the calcium channel alpha1 subunit were identified to substantially contribute to 1,4-dihydropyridine sensitivity. To determine whether these eight L-type residues (Thr1066, Gln1070, Ile1180, Ile1183, Tyr1490, Met1491, Ile1497, and Ile1498; alpha1C-a numbering) are sufficient to form a high affinity 1,4-dihydropyridine binding site in a non-L-type calcium channel, we transferred them to the 1, 4-dihydropyridine-insensitive alpha1A subunit using site-directed mutagenesis. 1,4-Dihydropyridine agonist and antagonist modulation of barium inward currents mediated by the mutant alpha1A subunits, coexpressed with alpha2delta and beta1a subunits in Xenopus laevis oocytes, was investigated with the two-microelectrode voltage clamp technique. The resulting mutant alpha1A-DHPi displayed low sensitivity for 1,4-dihydropyridines. Analysis of the 1,4-dihydropyridine binding region of an ancestral L-type alpha1 subunit previously cloned from Musca domestica body wall muscle led to the identification of Met1188 (alpha1C-a numbering) as an additional critical constituent of the L-type 1,4-dihydropyridine binding domain. The introduction of this residue into alpha1A-DHPi restored full sensitivity for 1,4-dihydropyridines. It also transferred functional properties considered hallmarks of 1, 4-dihydropyridine agonist and antagonist effects (i.e. stereoselectivity, voltage dependence of drug modulation, and agonist-induced shift in the voltage-dependence of activation). Our gain-of-function mutants provide an excellent model for future studies of the structure-activity relationship of 1, 4-dihydropyridines to obtain critical structural information for the development of drugs for neuronal, non-L-type calcium channels.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9346909     DOI: 10.1074/jbc.272.44.27686

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  19 in total

1.  Excitation-contraction coupling is unaffected by drastic alteration of the sequence surrounding residues L720-L764 of the alpha 1S II-III loop.

Authors:  C M Wilkens; N Kasielke; B E Flucher; K G Beam; M Grabner
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-24       Impact factor: 11.205

Review 2.  Molecular basis of drug interaction with L-type Ca2+ channels.

Authors:  J Mitterdorfer; M Grabner; R L Kraus; S Hering; H Prinz; H Glossmann; J Striessnig
Journal:  J Bioenerg Biomembr       Date:  1998-08       Impact factor: 2.945

Review 3.  Structural Basis for Pharmacology of Voltage-Gated Sodium and Calcium Channels.

Authors:  William A Catterall; Teresa M Swanson
Journal:  Mol Pharmacol       Date:  2015-04-06       Impact factor: 4.436

4.  The Cav1.2 N terminus contains a CaM kinase site that modulates channel trafficking and function.

Authors:  Brett A Simms; Ivana A Souza; Renata Rehak; Gerald W Zamponi
Journal:  Pflugers Arch       Date:  2014-05-28       Impact factor: 3.657

5.  A Single Amino Acid Determines the Selectivity and Efficacy of Selective Negative Allosteric Modulators of CaV1.3 L-Type Calcium Channels.

Authors:  Garry Cooper; Soosung Kang; Tamara Perez-Rosello; Jaime N Guzman; Daniel Galtieri; Zhong Xie; Jyothisri Kondapalli; Jack Mordell; Richard B Silverman; D James Surmeier
Journal:  ACS Chem Biol       Date:  2020-09-03       Impact factor: 5.100

6.  Distinct properties of amlodipine and nicardipine block of the voltage-dependent Ca2+ channels Cav1.2 and Cav2.1 and the mutant channels Cav1.2/dihydropyridine insensitive and Cav2.1/dihydropyridine sensitive.

Authors:  Min Lin; Oluyemi Aladejebi; Gregory H Hockerman
Journal:  Eur J Pharmacol       Date:  2011-09-02       Impact factor: 4.432

7.  Potentiation of the cardiac L-type Ca(2+) channel (alpha(1C)) by dihydropyridine agonist and strong depolarization occur via distinct mechanisms.

Authors:  C M Wilkens; M Grabner; K G Beam
Journal:  J Gen Physiol       Date:  2001-11       Impact factor: 4.086

Review 8.  L-Type Calcium Channels Modulation by Estradiol.

Authors:  Nelson E Vega-Vela; Daniel Osorio; Marco Avila-Rodriguez; Janneth Gonzalez; Luis Miguel García-Segura; Valentina Echeverria; George E Barreto
Journal:  Mol Neurobiol       Date:  2016-08-15       Impact factor: 5.590

Review 9.  Molecular pharmacology of high voltage-activated calcium channels.

Authors:  Clinton J Doering; Gerald W Zamponi
Journal:  J Bioenerg Biomembr       Date:  2003-12       Impact factor: 2.945

10.  Arachidonic acid inhibition of L-type calcium (CaV1.3b) channels varies with accessory CaVbeta subunits.

Authors:  Mandy L Roberts-Crowley; Ann R Rittenhouse
Journal:  J Gen Physiol       Date:  2009-04       Impact factor: 4.086

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.